Skip to Main Content

Paper Details

LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade.
Sci Transl Med
53
2021
CD8+, ICB, LAG, LAG+, LAG+ immunotype, LAG- immunotype, LAG-3, LAG-3+, LAG-3+CD8+ T cell population, PD-L1, Patients, cancer, immune cells, melanoma, patients, peripheral blood LAG+ immunotype, peripheral blood cells, tumor, urothelial carcinoma
Author NameAffiliation
Ronglai ShenMemorial Sloan Kettering Cancer Center
Arshi AroraMemorial Sloan Kettering Cancer Center
Travis J HollmannParker Institute for Cancer Immunotherapy
Travis J HollmannMemorial Sloan Kettering Cancer Center
Katherine S PanageasMemorial Sloan Kettering Cancer Center
  • 1 - 5

Datasets

Release 1.2